Search results

New facility will greatly enhance Australia’s capability in stress engineering for industry

ANSTO is coordinating and facilitating the calling of pre-concept papers for the next cycle of technical cooperative project proposals under the Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science and Technology for Asia and the Pacific (RCA) | IAEA

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

ANSTO has provided supporting experimental evidence of a highly unusual quantum state, a quantum spin liquid (QSL), in a two-dimensional material.

In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).

Research represents significant step towards developing vaccine

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.

Pioneering work on materials for energy production, such as lithium ion batteries, has made ANSTO a centre of specialist capabilities and expertise.

Outstanding individuals and teams have been recognised for their outstanding work, innovation, excellence in the 2025 ANSTO Awards. 

ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.